Diverse collection of blood-related medical conditions with ineffective production of the myeloid class of blood cells.
1A myelodysplastic syndrome was noted 83 months from the start of therapy.
2With these techniques, we studied a 61-year-old woman with a myelodysplastic syndrome.
3Case reports: A 76-year-old male with a known myelodysplastic syndrome presented with pneumonia.
4Additionally, two patients with primary mediastinal germ cell cancer developed a myelodysplastic syndrome.
5Sixteen children with myelodysplastic syndrome as defined by the French-American-British co-operative group are presented.
6The first patient developed myelogenous leukaemia soon after the myelodysplastic syndrome has been diagnosed.
7In three healthy subjects, we detected somatic aberrations characteristic of patients with myelodysplastic syndrome.
8Method: Prospective cohort study of 106 adults with chronic myelogenous leukemia or primary myelodysplastic syndrome.
9No acute myelogenous leukemia or myelodysplastic syndrome was observed.
10Treatment is feasible and well tolerated although myelodysplastic syndrome cases has been observed in some trials.
11Patients with refractory SAA are at risk of later clonal evolution to myelodysplastic syndrome and acute leukemia.
12Neither 13-Cis-Retinoic Acid nor Danazol appear active enough in patients with favorable myelodysplastic syndrome to justify their use.
13Its activation by chromosomal rearrangement induces a myelodysplastic syndrome with progression to acute myeloid leukemia of poor prognosis.
14One patient in aplastic anemia who achieved good response by ALG administration had a possible diagnosis of myelodysplastic syndrome.
15Chronic myelomonocytic leukaemia is a rare disease and data on the treatment are often extrapolated from myelodysplastic syndrome studies.
16The CMS avoided making a decision on EPO use for individuals with myelodysplastic syndrome, which often develops into leukemia.
Esta colocação é formada por:
Translations for myelodysplastic syndrome